Vinnova portfolio
The short answer
Vinnova has been named as an investor in 1 reported round worth about $98K in disclosed capital, backing MucoLife Therapeutics. Most recent: MucoLife Therapeutics (€91K, 2026-11-06).
- Deals logged
- 1
- Companies
- 1
- Disclosed rounds
- $98K
- Top sector
- —
Every deal on record
| Date | Company | Amount | Round | Source |
|---|---|---|---|---|
| 2026-11-06 | MucoLife Therapeutics | €91K | — | Tech.eu |
How this is measured
Deals come from public funding announcements, credited in the source column. Only investors named in reports are listed; nothing is estimated.